HOVR Closes Additional $25M Offering, Accelerating Dilution Amid Pre-Revenue Development

What happened

New Horizon Aircraft closed a $25M registered direct offering of 9.96M shares to the same institutional investors from its May 8 offering, following a $20M offering on May 6. The combined $45M raised in May injects immediate cash but adds roughly 20% to the share count in just one month. The company remains pre-revenue and has disclosed substantial doubt about its ability to fund operations beyond 12 months without further capital. While the funds extend the runway, the rapid pace of equity issuance signals ongoing financing pressure and raises concerns about the credibility of the 2027 flight-test target. The dilution overhang now dominates the narrative, outweighing engineering progress.

Implication

The back-to-back equity offerings underscore that HOVR remains dependent on capital markets for survival, with no revenue in sight. While the $25M injection provides near-term liquidity, it adds nearly 10 million shares, diluting existing holders substantially. The company's financing dependency is now the dominant narrative, overshadowing engineering progress. Investors should demand clear evidence of reduced cash burn and a dated flight-test plan before considering any position. Until then, the risk of further dilution and potential schedule slippage argues for staying on the sidelines.

Thesis delta

The thesis weakens significantly as the pace of dilution accelerates beyond expectations. The May 2026 offerings collectively raise over $45M but increase the share count by roughly 20% in one month. This suggests management is prioritizing immediate cash over shareholder value, and the implied timeline to flight testing may be longer than previously assumed.